Literature DB >> 26412464

Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment.

Erdogan Pekcan Erkan, Okay Saydam1.   

Abstract

Extracellular vesicles (EVs) are different types of membrane-derived vesicles that originate from the endosomal pathway or the plasma membrane. These vesicles are used as "carriers" in intercellular communication, and are responsible for the transfer of biological cargo (lipids, proteins, RNA species, and DNA) between different cells. Despite the shortcomings in our knowledge of EV biology, attempts to employ EVs as natural delivery tools for therapeutic purposes have been partly successful in different settings. In this review, we highlight this unique potential of EVs, and discuss previous examples and future scenarios.

Entities:  

Mesh:

Year:  2016        PMID: 26412464     DOI: 10.2174/1568009615666150923115439

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  3 in total

1.  The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency.

Authors:  Qingle Liang; Nana Bie; Tuying Yong; Ke Tang; Xiaolong Shi; Zhaohan Wei; Haibo Jia; Xiaoqiong Zhang; Haiyan Zhao; Wei Huang; Lu Gan; Bo Huang; Xiangliang Yang
Journal:  Nat Biomed Eng       Date:  2019-05-20       Impact factor: 25.671

2.  Eliminating the original cargos of glioblastoma cell-derived small extracellular vesicles for efficient drug delivery to glioblastoma with improved biosafety.

Authors:  Yuhang Guo; Guowen Hu; Yuguo Xia; HaiYan Li; Ji Yuan; Juntao Zhang; Yu Chen; Hua Guo; Yunlong Yang; Yang Wang; Zhifeng Deng
Journal:  Bioact Mater       Date:  2022-03-16

3.  SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma.

Authors:  Elisabet Ampudia-Mesias; Samia El-Hadad; Charles Scott Cameron; Adelheid Wöhrer; Thomas Ströbel; Nurten Saydam; Okay Saydam
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.